Alprostadil Continuous Intravenous Infusion in Bridging Cardiac Transplant in Severe Heart Failure Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00610051
Recruitment Status : Suspended (DD issue)
First Posted : February 7, 2008
Last Update Posted : January 31, 2017
Information provided by (Responsible Party):
Biopeutics Co., Ltd

No Study Results Posted on for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : June 2021
  Estimated Study Completion Date : December 2022